Biotech News

Fulgent Reports Third Quarter 2025 Financial Results

ir.fulgentgenetics.com2026-05-06 15:27 EST

Revenue of $84.1 million , growing 17% year-over-year Raising Full Year 2025 Revenue Guidance to $325.0 million Raising Full Year 2025 EPS Guidance to GAAP loss of approximately ( $1.70 ) per share and Non-GAAP income of $0.30 per share GAAP gross profit of $35.5 million , or GAAP gross margin of

Full article